Elvitegravir
CAS: 697761-98-1
Ref. TM-T2332
| 5mg | 51.00 € | ||
| 10mg | 86.00 € | ||
| 25mg | 149.00 € | ||
| 50mg | 279.00 € | ||
| 100mg | 451.00 € | ||
| 1mL*10mM (DMSO) | 52.00 € |
Estimated delivery in United States, on Monday 13 Jan 2025
Product Information
Name:
Elvitegravir
Synonyms:
- JTK-303
- GS-9137
- EVG
- D06677
- (S)-6-(3-Chloro-2-fluorobenzyl)-1-(1-hydroxy-3-methylbutan-2-yl)-7-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid
- 1,4-Dihydro-6-(3-chloro-2-fluorobenzyl)-7-methoxy-1-[(1S)-1-(hydroxymethyl)-2-methylpropyl]-4-oxo-3-quinolinecarboxylic acid
- 3-Quinolinecarboxylic acid, 6-[(3-chloro-2-fluorophenyl)methyl]-1,4-dihydro-1-[(1S)-1-(hydroxymethyl)-2-methylpropyl]-7-methoxy-4-oxo-
- 6-(3-Chloro-2-Fluorobenzyl)-1-[1-(Hydroxymethyl)-2-Methylpropyl]-7-Methoxy-4-Oxo-1,4-Dihydroquinoline-3-Carboxylic Acid
- 6-(3-Chloro-2-fluorobenzyl)-1-[(S)-1-hydroxymethyl-2-methylpropyl]-7-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid
- 6-(3-Chloro-2-fluorobenzyl)-1-[1(S)-(hydroxymethyl)-2-methylpropyl]-7-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid
- See more synonyms
- 6-[(3-Chloro-2-fluorophenyl)methyl]-1,4-dihydro-1-[(1S)-1-(hydroxymethyl)-2-methylpropyl]-7-methoxy-4-oxo-3-quinolinecarboxylic acid
- Gs-9137
- Jtk-303
- Vitekta
Description:
Elvitegravir (JTK-303) is an HIV integrase inhibitor and CYP2C9 inducer.
Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Targetmol
Long term storage:
Notes:
Chemical properties
Molecular weight:
447.88
Formula:
C23H23ClFNO5
Purity:
98.35% - 99.73%
Color/Form:
Solid
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:
Technical inquiry about: TM-T2332 Elvitegravir
Please use instead the cart to request a quotation or an order
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
